Comments
Loading...

Viking Therapeutics

VKTXNASDAQ
Logo brought to you by Benzinga Data
$66.20
1.752.72%
Pre-Market: 6:59 AM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$138.00
Lowest Price Target1
$12.00
Consensus Price Target1
$79.87

Viking Therapeutics (NASDAQ:VKTX) Stock, Analyst Ratings, Price Targets, Forecasts

Viking Therapeutics Inc has a consensus price target of $79.87 based on the ratings of 15 analysts. The high is $138 issued by Oppenheimer on March 27, 2024. The low is $12 issued by SVB Leerink on April 28, 2022. The 3 most-recent analyst ratings were released by Morgan Stanley, JP Morgan, and Raymond James on September 12, 2024, September 11, 2024, and July 25, 2024, respectively. With an average price target of $101 between Morgan Stanley, JP Morgan, and Raymond James, there's an implied 52.57% upside for Viking Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
May
2
Jun
1
Jul
2
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Morgan Stanley
JP Morgan
Raymond James
HC Wainwright & Co.
Truist Securities

1calculated from analyst ratings

Analyst Ratings for Viking Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Viking Therapeutics (VKTX) stock?

A

The latest price target for Viking Therapeutics (NASDAQ:VKTX) was reported by Morgan Stanley on September 12, 2024. The analyst firm set a price target for $105.00 expecting VKTX to rise to within 12 months (a possible 58.61% upside). 31 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Viking Therapeutics (VKTX)?

A

The latest analyst rating for Viking Therapeutics (NASDAQ:VKTX) was provided by Morgan Stanley, and Viking Therapeutics reiterated their overweight rating.

Q

When was the last upgrade for Viking Therapeutics (VKTX)?

A

The last upgrade for Viking Therapeutics Inc happened on May 16, 2024 when Raymond James raised their price target to $116. Raymond James previously had an outperform for Viking Therapeutics Inc.

Q

When was the last downgrade for Viking Therapeutics (VKTX)?

A

There is no last downgrade for Viking Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Viking Therapeutics (VKTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Viking Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Viking Therapeutics was filed on September 12, 2024 so you should expect the next rating to be made available sometime around September 12, 2025.

Q

Is the Analyst Rating Viking Therapeutics (VKTX) correct?

A

While ratings are subjective and will change, the latest Viking Therapeutics (VKTX) rating was a reiterated with a price target of $105.00 to $105.00. The current price Viking Therapeutics (VKTX) is trading at is $66.20, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch